Skip to main content

Lupus Science & Medicine™

Lupus Science & Medicine™ is a peer-reviewed, open access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking lupus studies. Lupus Science & Medicine™ is owned by the Lupus Foundation of America and published by BMJ, a respected global provider of evidence-based medical knowledge.

Lupus Science & Medicine™ is edited by Jill P. Buyon, Division Director of Rheumatology, Professor of Medicine at New York University School of Medicine; and Ronald F. van Vollenhoven, Professor and Chief, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden. The journal has also assembled a world-class team of associate editors and an editorial board to maintain the journal's high standards, high visibility, and credibility.

Research on lupus will be considered from fields including, but not limited to, rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry. Submissions from groups of investigators engaged in international collaborations are especially encouraged.  

We invite you to:

Lupus Science & Medicine™ complements the Lupus Foundation of America’s national research program, which pursues an aggressive agenda to tackle the biggest challenges in lupus and find answers to the most important questions

Watch as co-editors-in-chief Dr. Jill Buyon and Prof. Ronald van Vollenhoven discuss how the journal is contributing to lupus research advancements. This interview was conducted at the American College of Rheumatology 2017 Annual Scientific Meeting.